tirzepatide mechanism of action for weight loss (Mounjaro/Zepbound): Research Guide tirzepatide.pptx

In patients with advanced T2D uncontrolled on insulin with or without metformin (PIONEER 8), oral semaglutide significantly reduced HbA 1c compared with placebo at Week 26 (ETD: 0.5% [3 mg] to 1.2% [14 mg]

It is not legally interchangeable with brand-name Zepbound or Mounjaro

It can also help avoid taking a damaged or ineffective dose

5* all the way

Here is the distribution

In longer-term studies involving patients with carotid artery stenosis, the same 50 mL daily dose, taken consistently for up to one year, was associated with a ~3035% reduction in carotid intima-media thickness (IMT), a structural marker of plaque burden and cardiovascular risk